Karolinska Schizophrenia Project: Brain study for first episode psychosis
Part of Mental health clinical trials.
This study examines the brain in people having their first episode of psychosis (like hearing voices or strong false beliefs) to understand more about schizophrenia and related conditions. It involves MRI scans and other tests over one year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having your first episode of psychosis (such as schizophrenia or delusional disorder).
- You have started taking antipsychotic medication less than 4 weeks ago.
- You do not have another major mental health condition that better explains your symptoms.
- You have no serious physical illness, brain injury, or history of seizures.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You have no metal in your body and are not claustrophobic in MRI machines.
- You do not have a current substance use disorder (nicotine use is okay).
- You are not taking blood-thinning medication within 2 weeks of certain procedures.
- You have not donated blood or plasma recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with early psychosis, or a high risk of developing psychosis, to better understand brain and symptom changes over time. It may help future prevention or treatment by comparing brain/clinical measurements between people who are at risk, recently affected, and healthy controls.
This study explores how thinking and memory work in people who have experienced early psychosis. It involves computer tasks, brain scans, and a type of brain stimulation to better understand cognition. The study has two parts: one for people currently in early psychosis and one for people who have had psychosis at any point.
This study uses brain scans to find markers that can predict how well antipsychotic medications work in people having their first episode of psychosis. It aims to help doctors choose the right treatment earlier.
This study looks at how to improve early psychosis care using data-driven planning and support for people who are newly developing symptoms. It may help by sharing better ways to coordinate treatment among patients, families, and the clinic/community teams.
This study looks at whether special body and brain markers can predict how a person’s symptoms change over two years after a first psychotic episode. It may also help doctors understand who responds better to treatment, so future care can be more personalized.
This trial looks at people having a first psychotic episode who have not yet taken anti-psychotic medicine. It aims to see whether an early support approach can help, before other treatments become necessary.
Hear when a new Schizophrenia and Disorders with Psychotic Features trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.